Similar articles

• Detection of antibodies to Plasmodium falciparum sporozoites by employing synthetic peptides.

  Del Giudice G, Biro S, Degrémont AA, Engers HD, Lambert PH, Pessi A, Tougne C, Verdini AS, Weiss N, Tanner M. Del Giudice G, et al. Parassitologia. 1986 Aug-Dec;28(2-3):107-11. Parassitologia. 1986. PMID: 3332303
• The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation.

  Good MF, Kumar S, Miller LH. Good MF, et al. Immunol Today. 1988 Nov;9(11):351-5. doi: 10.1016/0167-5699(88)91336-9. Immunol Today. 1988. PMID: 3076406 Review. No abstract available.
• Vaccines for human malaria: epidemiological and immunological perspectives.

  Webster HK, Diggs CL, Ballou WR, Chulay JD. Webster HK, et al. Southeast Asian J Trop Med Public Health. 1988 Sep;19(3):375-89. Southeast Asian J Trop Med Public Health. 1988. PMID: 3064321 Review. No abstract available.
• Sporozoite immunity and vaccine development.

  Hockmeyer WT, Ballou WR. Hockmeyer WT, et al. Prog Allergy. 1988;41:1-14. Prog Allergy. 1988. PMID: 3043419 Review. No abstract available.
• Target antigens of malaria transmission blocking immunity.

  Kaushal DC, Carter R, Miller LH. Kaushal DC, et al. J Commun Dis. 1987 Dec;19(4):417-21. J Commun Dis. 1987. PMID: 3507450 No abstract available.